Skip to navigation

If you're reading this, it may be time to upgrade your browser.

Faculty

Leonard E. Weisman, M.D.

Leonard E. Weisman, M.D.

Academic Appointments

  • Professor of Pediatrics—Neonatology

Clinical Titles

  • Director, Texas Children's Hospital Perinatal Center

Board Certifications

  • Pediatrics
  • Neonatal-Perinatal Medicine

Current Positions in Professional Organizations

  • Member, Advisory Board, Ronald McDonald House Houston
  • Member, Perinatal Infections Committee, World Association of Perinatal Medicine
  • Member, Committee on Maternal and Prenatal Health, Texas Medical Association
  • Alternate Delegate, Texas Medical Association House of Delegates
  • Member, Committee on Fetus and Newborn, Texas Pediatric Society
  • Member, Committee on Legislation, Texas Pediatric Society
  • Trustee, West Point Jewish Chapel Fund

Professional History

  • M.D., Baylor College of Medicine, Houston TX, 1974
  • Pediatric Intern, Fitzsimons Army Medical Center, Aurora CO, 1974–1975
  • Pediatric Resident, Fitzsimons Army Medical Center, Aurora CO, 1975–1977
  • Neonatal-Perinatal Medicine Fellow, Fitzsimons Army Medical Center, Aurora CO, 1979–1981

Academic Interests

  • Laboratory studies evaluating the impact of immune modulators on common perinatal infections (eg, Streptococcus, Staphylococcus, Ureaplasma, Candida, etc.)
  • Clinical studies of the epidemiology, pathology, pathophysiology, and microbiology, of common perinatal infections, and the effectivenes of prevention or treatment strategies

Recent Publications

  1. Weisman LE. Motavizumab (Numax™) in the prevention and treatment of respiratory tract infection due to respiratory syncytial virus (RSV). Current Opinion in Investigational Drugs. 2008 (in press).
  2. Coll JO, Menendez C, Botet F, Dayal R and the WAPM Perinatal Infections Working Group: Carbonell-Estrany X (coordinator), Weisman LE, Anceschi MM, Greenough A, Gibbs R, Ville Y. Treatment and prevention of malaria in pregnancy and newborn. Journal of Perinatal Medicine. 2008;36(1):15-29.
  3. Oluola O, Fein M, Kong L, Weisman LE. Lysostaphin in treatment of neonatal Staphylococcus aureus infection. Antimicrobial Agents and Chemotherapeutics 2007; 51(6):2198–2200.
  4. Venkatesh MP, Weisman LE. A Neonatal Co-infection model of Staphylococcus epidermidis and Candida albicans: Fluconazole Prophylaxis Enhances Survival and Growth. Antimicrobial Agents and Chemotherapeutics 2007; 51(4):1240–1245. Epub 2007 Jan 29.
  5. Weisman LE. Ureaplasma and preterm birth. Progres en Neonatologie 2007; 27:483–490.
  6. Weisman LE. Antibody for the Prevention of Neonatal Nosocomial Staphylococcal Infection. Archives de Pédiatrie. 14:S31-S34, 2007.